fda glp-1 warning letters september 2025 news Prescription Drug Freight Fraud, June 2026 report – Partnership for Safe Medicines FDA Sends Warning Letters to

6 Although metformin is usually an effective treatment for regulating glucose levels, many patients with T2D have an elevated risk of cardiac events that does not improve in response to metformin

avoid highfat meals to reduce seizure risk (MedlinePlus, 2024

One limitation of the current literature is the lack of extensive clinical studies exploring the direct neuroprotective effects of GLP-1RAs in human populations

The fatty acid conjugation that gives semaglutide its extended half-life adds another layer of manufacturing complexity

An October survey of 205 companies by the International Foundation of Employee Benefit Plans found 76% of respondents provided GLP-1 drug coverage for diabetes, versus only 27% that provided coverage for weight loss